Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset
November 20, 2024 | 19:01
Acurx Pharmaceuticals, Inc., a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that the Company's Board of Directors approved the purchase of up to $1 million in Bitcoin to hold as a treasury reserve asset.
Mobile Version